Vontobel Holding AG (0QKE)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 90.05 |
|---|---|
| 52-week range | 58.20 – 94.70 |
| Return, 1 month / 3 months | −2.1% / +11.7% |
| Return, 1 year / 3 years | +51.7% / +68.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 19.6% |
| Worst drawdown (1 year) | -9.5% |
| Average daily value traded | 0.89M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vontobel Holding is a Swiss banking group based in Zurich that provides wealth management and asset management services. It serves private clients, institutional investors and financial intermediaries, offering portfolio management, investment advice and investment funds. Through its investment banking activities it issues structured products and provides securities and trading services. The group operates from Switzerland and through offices in other financial centres, serving clients with cross-border and domestic needs.
The shares are listed on the London Exchange in UK under the code 0QKE, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vontobel Holding AG (0QKE) trades on the London Exchange in UK. It last closed at GBP 90.05 on 22 October 2026.
Its price-based Market X-Ray is 83 out of 100 (a strong price profile), ranking 19 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 51.7% and over the last three months it rose 11.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.2% | ||
| From 52-week high | -4.2% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.7% | ||
| 6-month return | 33.9% | ||
| 12-month return, skipping the last month | 54.9% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -9.5% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.89M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | −2.1% |
| 3 months | +11.7% |
| 6 months | +33.9% |
| 1 year | +51.7% |
| 3 years | +68.3% |
| 5 years | +6.6% |
Signals
| 50-day / 200-day average | 90.65 / 76.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Apr 2026 | GBX 0.0300 |
| 4 Apr 2025 | GBX 0.0300 |
| 11 Apr 2024 | GBX 0.0300 |
| 6 Apr 2023 | GBX 0.0300 |
| 8 Apr 2022 | GBX 0.0300 |
| 22 Apr 2021 | GBX 0.0225 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.